Correlation Between Corvus Pharmaceuticals and Paratek Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Paratek Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Paratek Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Corvus Pharmaceuticals and Paratek Pharmaceuticals, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Paratek Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Paratek Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Paratek Pharmaceuticals.

Diversification Opportunities for Corvus Pharmaceuticals and Paratek Pharmaceuticals

0.0

Correlation Coefficient

Corvus Pharmaceuticals  Paratek Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Corvus and Paratek is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Paratek Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paratek Pharmaceuticals and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Paratek Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paratek Pharmaceuticals has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Paratek Pharmaceuticals go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Paratek Pharmaceuticals

If you would invest (100.00) in Paratek Pharmaceuticals on December 1, 2024 and sell it today you would earn a total of  100.00  from holding Paratek Pharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Corvus Pharmaceuticals  vs.  Paratek Pharmaceuticals

Corvus Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Corvus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Paratek Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Paratek Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Paratek Pharmaceuticals is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Corvus Pharmaceuticals and Paratek Pharmaceuticals

The main advantage of trading using opposite Corvus Pharmaceuticals and Paratek Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Paratek Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paratek Pharmaceuticals will offset losses from the drop in Paratek Pharmaceuticals' long position.

The idea behind Corvus Pharmaceuticals and Paratek Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.